Literature DB >> 25317048

Ovarian aging and premature ovarian failure.

Yavuz Emre Sükür1, Içten Balık Kıvançlı2, Batuhan Ozmen3.   

Abstract

Physiological reproductive aging occurs as a result of a decrease in the number and quality of oocytes in ovarian cortex follicles. Although the reason for the decrease in the quality of the pool and follicular oocytes is not fully understood, endocrine, paracrine, genetic, and metabolic factors are thought to be effective. Nowadays, in order to understand the mechanisms of ovarian aging, genomic research has gained importance. The effect of co-factors, such as telomerase and ceramide, in the ovarian aging process is only getting ascertained with new research studies. The most important tests in the assessment of ovarian aging are antral follicle count and anti-Mullerian hormone.

Entities:  

Keywords:  Ovarian aging; premature ovarian failure; reproduction

Year:  2014        PMID: 25317048      PMCID: PMC4195330          DOI: 10.5152/jtgga.2014.0022

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  91 in total

1.  Inhibin: a candidate gene for premature ovarian failure.

Authors:  A N Shelling; K A Burton; A L Chand; C C van Ee; J T France; C M Farquhar; S R Milsom; D R Love; K Gersak; K Aittomäki; I M Winship
Journal:  Hum Reprod       Date:  2000-12       Impact factor: 6.918

Review 2.  Genetic studies to identify genes underlying menopausal age.

Authors:  Helen S Kok; Kristel M van Asselt; Yvonne T van der Schouw; Petra H M Peeters; Cisca Wijmenga
Journal:  Hum Reprod Update       Date:  2005-07-15       Impact factor: 15.610

3.  The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.

Authors:  M Dólleman; M J Faddy; J van Disseldorp; Y T van der Schouw; C M Messow; B Leader; P H M Peeters; A McConnachie; S M Nelson; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2013-03-18       Impact factor: 5.958

4.  Present and future options for the preservation of fertility in female adolescents with cancer.

Authors:  C C M Beerendonk; D D M Braat
Journal:  Endocr Dev       Date:  2005

5.  Fertility results after ovarian transposition for pelvic malignancies treated by external irradiation or brachytherapy.

Authors:  P Morice; R Thiam-Ba; D Castaigne; C Haie-Meder; A Gerbaulet; P Pautier; P Duvillard; G Michel
Journal:  Hum Reprod       Date:  1998-03       Impact factor: 6.918

6.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

7.  Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women.

Authors:  P van Zonneveld; G J Scheffer; F J M Broekmans; M A Blankenstein; F H de Jong; C W N Looman; J D F Habbema; E R te Velde
Journal:  Hum Reprod       Date:  2003-03       Impact factor: 6.918

8.  A new statistical approach demonstrated menstrual patterns during the menopausal transition did not vary by age at menopause.

Authors:  Lynda Lisabeth; Sioban Harlow; Bahjat Qaqish
Journal:  J Clin Epidemiol       Date:  2004-05       Impact factor: 6.437

Review 9.  Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

Authors:  A La Marca; G Sighinolfi; D Radi; C Argento; E Baraldi; A Carducci Artenisio; G Stabile; A Volpe
Journal:  Hum Reprod Update       Date:  2009-09-30       Impact factor: 15.610

10.  Genome-wide association studies identify loci associated with age at menarche and age at natural menopause.

Authors:  Chunyan He; Peter Kraft; Constance Chen; Julie E Buring; Guillaume Paré; Susan E Hankinson; Stephen J Chanock; Paul M Ridker; David J Hunter; Daniel I Chasman
Journal:  Nat Genet       Date:  2009-05-17       Impact factor: 38.330

View more
  19 in total

Review 1.  The impact of FMR1 gene mutations on human reproduction and development: a systematic review.

Authors:  Vincenzo Noto; Conor Harrity; David Walsh; Kevin Marron
Journal:  J Assist Reprod Genet       Date:  2016-07-18       Impact factor: 3.412

Review 2.  Emerging Roles for Maf1 beyond the Regulation of RNA Polymerase III Activity.

Authors:  Akshat Khanna; Ajay Pradhan; Sean P Curran
Journal:  J Mol Biol       Date:  2015-07-11       Impact factor: 5.469

3.  The protective effect of platelet-rich plasma administrated on ovarian function in female rats with Cy-induced ovarian damage.

Authors:  Pinar Ozcan; Taha Takmaz; Olgu Enis Tok; Sevde Islek; Esra Nur Yigit; Cem Ficicioglu
Journal:  J Assist Reprod Genet       Date:  2020-02-04       Impact factor: 3.412

4.  Effects of VEGF + Mesenchymal Stem Cells and Platelet-Rich Plasma on Inbred Rat Ovarian Functions in Cyclophosphamide-Induced Premature Ovarian Insufficiency Model.

Authors:  Birol Vural; Gokhan Duruksu; Fisun Vural; Merve Gorguc; Erdal Karaoz
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

5.  Protective Effects of Puerarin on Premature Ovarian Failure via Regulation of Wnt/β-catenin Signaling Pathway and Oxidative Stress.

Authors:  Cheng Chen; Song Li; Cong Hu; Weiwei Cao; Qingfeng Fu; Jia Li; Liping Zheng; Jian Huang
Journal:  Reprod Sci       Date:  2020-09-29       Impact factor: 3.060

Review 6.  Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature.

Authors:  Prosper Igboeli; Abdeljabar El Andaloussi; Ujalla Sheikh; Hajra Takala; Amro ElSharoud; Ashley McHugh; Larisa Gavrilova-Jordan; Steven Levy; Ayman Al-Hendy
Journal:  J Med Case Rep       Date:  2020-07-18

7.  Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat Model.

Authors:  Dan Song; Yun Zhong; Chunfeng Qian; Qinyan Zou; Jian Ou; Yichao Shi; Liang Gao; Gaigai Wang; Zhenxing Liu; Haibo Li; Hailei Ding; Huihua Wu; Fuxin Wang; Jing Wang; Hong Li
Journal:  Biomed Res Int       Date:  2016-03-07       Impact factor: 3.411

Review 8.  Early menopause: A hazard to a woman's health.

Authors:  Claudio Hernández-Angeles; Camil Castelo-Branco
Journal:  Indian J Med Res       Date:  2016-04       Impact factor: 2.375

9.  Research on Establishment of Abnormal Phlegmatic Syndrome with Premature Ovarian Failure Rat Model and Effects of Balgham Munziq Treatment.

Authors:  Muladili Yuemaier; Mayire Tuerhong; Abulizi Keremu; Nafeisha Kadeer; Ayiguzhali Aimaiti; Xilinguli Wushouer; Adilijiang Yiming; Xiamixinuer Yilike
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-26       Impact factor: 2.629

10.  Effect of stem cell transplantation of premature ovarian failure in animal models and patients: A meta-analysis and case report.

Authors:  Lei Chen; Shilei Guo; Cui Wei; Honglan Li; Haiya Wang; Yan Xu
Journal:  Exp Ther Med       Date:  2018-03-20       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.